The differences between the two strains are also related to a different modulation in T24 (human urinary bladder transitional cell carcinoma) cells of inflammation mediators such as pro-inflammatory cytokines IL-6, IL-8 and IL-1β and the anti-inflammatory cytokine TGF-β. Here, CXCL8 is linked to bladder transitional cell carcinoma.